Disease Epidemiology / Clinical Course / Cancer

(B-023) A novel salivary-based companion diagnostic device for early detection and monitoring of HER-2+ breast cancer patients in resource-limited settings

(B-011) Association Between Non-adherence to Oral Anticancer Monotherapy in Clinical Trials (CTs) and Progression-Free Survival (PFS) in Patients (pts) with R/R Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

(B-002) Association of new-onset hypertension and its treatment with survival in cancer patients: A retrospective cohort study using electronic medical record data.

(B-014) Bayesian Analysis of Linear Tumor Growth Rate: Case Study in VHL Disease

(B-012) Comorbidity Assessment using Integrated EHR and Claims in a National Oncology Database

(B-008) Comparing approaches to real-world progression-free survival estimation among patients with advanced melanoma on first-line immunotherapy

(B-003) DARWIN EU® - Prevalence of Frailty and Polypharmacy in Selected Cancers: results from Six European Countries in a Real-World Context

(B-018) Estimating the incidence and prevalencehe incidence of second primary malignancy in men diagnosed with prostate cancer in the US during 2000-2022, as recorded in the US SEER 17 Registries

(B-005) Factors Affected the Short-term Mortality in Patients with Non-Small Cell Lung Cancer

(B-015) Harnessing Real-World Clinicogenomics for Non-Small Cell Lung Cancer Drug Development: An Initial Report

(B-001) Impact of gabapentinoids use on healthcare utilization and expenditure among female breast cancer survivors in the United States: A propensity-score matched cohort study

(B-020) Incidence and Risk Factors of chemotherapy-induced Nephrotoxicity in Cancer Patients with Proper Hydration and Dose Adjustments: A Prospective Hospital-based Study

(B-010) Incidence Trends and Characterisation of Lung Cancer: a Multinational European Cohort Study

(B-022) Integrated Multi-Setting Real-World Data to Advance Bladder Cancer Evidence Generation

(A-074) Interventions for Improving the Uptake of Preventive Medication Treatments for Breast Cancer: A Systematic Review

(B-006) Prediction Models for Diagnosis and Prognosis of Leukemia: Systematic Review and Critical Appraisal

(B-024) Predictors of Skin Melanoma among Adult population and Its Impact on Quality of Life in the U.S.

(B-019) Prevalence of Chronic Myeloid Leukemia in the European Union

(B-017) Real-World Data Survival Patterns in Glioblastoma Patients

(B-004) Risk of Cancer in Patients with First-Time Seizure: A Population-Based Cohort Study

(B-021) The value of integrating multi-care settings real world data for understanding prostate cancer management

(B-013) Treatment Patterns on Early-Stage Melanoma: Results from a Multi-site Chart Review

(B-016) Trends in the Incidence of Monoclonal Gammopathy of Undetermined Significance (MGUS) Before and During the COVID-19 Pandemic

(B-007) Updated Trends in incidence, prevalence, and survival in patients with Head and Neck Squamous Cell Carcinoma in the United States

(B-009) Validity of Hospital Cancer Registry and Electronic Health Record Cancer Diagnoses Among a Large Academic-Community Health System in the United States